ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,464Medicare Part D Prescriptions Filled, Including Refills

Rank: 207 out of 1844

$629K Total Retail Price of All Prescriptions

Rank: 207 out of 1844

360 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 9,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 474 411 S3 1 2
SIMVASTATIN 400 323 2 3
LEVOTHYROXINE SODIUM 363 308 3 1
LISINOPRIL 327 300 4 4
AMLODIPINE BESYLATE 285 255 5 6
CITALOPRAM HBR 269 251 6 19
FUROSEMIDE 239 219 7 7
DONEPEZIL HCL 227 227 8 26
OMEPRAZOLE 212 206 9 5
WARFARIN SODIUM 209 205 10 13
NAMENDA 193 193 11 33
CYMBALTA 162 128 12 36
METOPROLOL SUCCINATE 159 157 13 14
TRAMADOL HCL 151 143 14 18
SUBOXONE 131 17 15 188
ATORVASTATIN CALCIUM 131 123 15 12
METOPROLOL TARTRATE 129 114 17 11
POLYETHYLENE GLYCOL 3350 121 119 18 39
LOSARTAN POTASSIUM 118 115 19 24
AZITHROMYCIN 109 97 20 37
GABAPENTIN 103 91 21 15
CLOPIDOGREL 102 94 22 34
TORSEMIDE 94 82 23 118
POTASSIUM CHLORIDE 93 91 24 16
CEFUROXIME 90 83 25 184
METFORMIN HCL ER 88 62 26 46
ALENDRONATE SODIUM 85 85 27 25
ATENOLOL 82 78 28 17
SYNTHROID 82 76 28 55
HYDROCHLOROTHIAZIDE 81 56 30 9
PREDNISONE 80 71 31 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 67 31 20
QUETIAPINE FUMARATE 77 74 33 82
ISOSORBIDE MONONITRATE ER 75 75 34 59
HYDROXYCHLOROQUINE SULFATE 73 73 35 268
SERTRALINE HCL 72 59 36 21
PRAVASTATIN SODIUM 70 65 37 10
MIRTAZAPINE 68 50 38 49
OLANZAPINE 68 64 38 117
MELOXICAM 66 50 40 28
RANITIDINE HCL 63 59 41 38
ESCITALOPRAM OXALATE 63 61 41 52
LANTUS 63 61 41 42
HYDRALAZINE HCL 62 61 44 120
TAMSULOSIN HCL 61 61 45 27
LYRICA 56 48 46 92
FLUOXETINE HCL 56 53 46 41
EXELON 56 56 46 112
VERAPAMIL ER 55 45 49 98
PLAVIX 55 50 49 61
SPIRONOLACTONE 54 54 51 60
BUSPIRONE HCL 53 52 52 127
DIOVAN 53 53 52 58
OXYCODONE HCL 51 50 S2 54 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.